PubMed:11106653 / 0-176 JSONTXT

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":31,"end":42},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}

{"project":"Glycosmos6-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":31,"end":42},"obj":"http://www.glycoepitope.jp/epitopes/EP0081"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}

{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":128},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":31,"end":42},"obj":"https://glytoucan.org/Structures/Glycans/G43702JT"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}

{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":0,"end":7},"obj":"Disease"},{"id":"T2","span":{"begin":132,"end":151},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0019065"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}

{"project":"HP-phenotype","denotations":[{"id":"T1","span":{"begin":132,"end":151},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0002511"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}

{"project":"Glycan-GlyCosmos","denotations":[{"id":"T1","span":{"begin":31,"end":42},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G43702JT"},{"id":"A14","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}

{"project":"GlyCosmos-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":31,"end":42},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0081"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":132,"end":151},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0002511"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T1","span":{"begin":0,"end":7},"obj":"Disease"},{"id":"T2","span":{"begin":132,"end":151},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0019065"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}

{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":128},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T1","span":{"begin":0,"end":128},"obj":"Sentence"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":31,"end":42},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G43702JT"},{"id":"A14","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}

{"project":"GlyCosmos15-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":31,"end":42},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0081"}],"text":"Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development.\nIn Alzheimer's disease, the major pathological "}